AMPD1 Is Associated With the Immune Response and Serves as a Prognostic Marker in HER2-Positive Breast Cancer

BACKGROUND: Although immunotherapy has been used in the treatment of metastatic triple negative breast cancer (TNBC), its therapeutic influence on human epidermal growth factor receptor 2 (HER2)-positive subtype remains controversial. It is therefore imperative to find biomarkers that can predict th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Long, Zhang, Xue, Wang, Mengxue, Li, Yunhai, Xu, Jiali, Wei, Jiaying, Li, Hongzhong, Ren, Guosheng, Yin, Xuedong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660114/
https://www.ncbi.nlm.nih.gov/pubmed/34900696
http://dx.doi.org/10.3389/fonc.2021.749135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660114/
https://www.ncbi.nlm.nih.gov/pubmed/34900696
http://dx.doi.org/10.3389/fonc.2021.749135

Ejemplares similares